Compare Deere & Company (DE) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deere & Company vs Oscar Health Inc — how do they compare? Deere & Company trades at $620.93 (market cap $175.95B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Deere & Company is far larger — about 17.2× Oscar Health Inc's market cap, and Deere & Company pays a 0.99% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Deere & Company for 75 Days and Oscar Health Inc for 15 Days on average.
| DE | OSCR | |
|---|---|---|
Market Cap | $175.95B | $10.22B |
Volume | 1,387,231 | 4,123,394 |
Sector | Industrials | Health |
52-Week High | $709.48 | $33.81 |
52-Week Low | $439.11 | $10.85 |
Typical Hold Time | 75 Days | 15 Days |
Enterprise Value | $229.85B | $6.57B |
Dividend Yield | 0.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deere & Company (DE) trades at $652.58, down 0.65% on the day, with the stock showing mixed signals. The technical picture is bearish with key support at $642 and resistance at $660, while fundamentals reveal declining revenue from $44.67B in 2025 to projected $46.9B in 2026, though earnings have consistently beaten estimates. Analyst consensus remains positive with a $731.20 price target, and the company maintains strong profitability with 10.39% net margin and 18.4% ROE.
The outlook for DE is cautiously optimistic despite near-term headwinds. While agricultural equipment cycle pressures and declining revenue pose risks, consistent earnings beats, strong cash flow generation, and strategic AI initiatives position the company for recovery. The current valuation at 36.27 P/E appears stretched relative to earnings decline, creating a balanced risk-reward profile for long-term investors.
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Read more on DE →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
